Tsai James C

Riina Nicholas, Harris Alon, Siesky Brent A, Ritzer Lukas, Pasquale Louis R, Tsai James C et al.

AI models found OCTA vascular biomarkers are as effective as OCT structural biomarkers for diagnosing primary open-angle glaucoma, offering new diagnostic avenues.

Tsai James C

Radell Jake E, Sharma Himanshu K, Auyeung Kelsey L, Paul Megan E, Gagliuso Donna J, Chadha Nisha et al.

This real-world study found latanoprostene bunod effectively and safely lowered intraocular pressure in glaucoma patients, suggesting it's a valuable treatment option, potentially superior to traditional PGAs.

Kolomeyer Natasha N, Drinkwater Owen J, Drivas Eleni, Zakik Amir, Zemon Vance, Sidoti Paul A et al.

Kolomeyer Natasha N, Drinkwater Owen J, Drivas Eleni, Zakik Amir, Zemon Vance, Sidoti Paul A et al.

This study found modified icVEP testing detects functional glaucoma damage, even preperimetric, and differentiates severity. This suggests icVEP could complement standard perimetry for glaucoma assessment.

Kaplowitz Kevin, Tsai James C

Kaplowitz Kevin, Khodadadeh Sarah, Wang Samantha, Lee Daniel, Tsai James C

Subconjunctival 5-FU for failing Ahmed implants sustained long-term IOP reduction, with 5-year outcomes similar to controls, suggesting it can prolong shunt efficacy.

Christakis Panos G, Zhang Dongyu, Budenz Donald L, Barton Keith, Tsai James C, Ahmed Iqbal I K

This 5-year study found Baerveldt implants achieved better IOP control and lower failure rates than Ahmed implants for glaucoma, but with a higher hypotony risk.

Cohen Amir, Wong Sze H, Patel Shriji, Tsai James C

This review explores endoscopic cyclophotocoagulation (ECP) for glaucoma, assessing its safety and effectiveness across various disease stages, noting its expanded use beyond refractory cases.

Christakis Panos G, Kalenak Jeffrey W, Tsai James C, Zurakowski David, Kammer Jeffrey A, Harasymowycz Paul J et al.

Comparing Ahmed vs. Baerveldt glaucoma implants, Baerveldt showed lower 5-year failure rates and better IOP control with fewer medications, but had a small hypotony risk not seen with Ahmed.

Wang Xingxing, Lin Jun, Arzeno Alexander, Choi Jin Young, Boccio Juliann, Frieden Eric et al.

Intravitreal NgR1-blocking protein was studied. It promoted axon regeneration after injury and protected large retinal ganglion cells in glaucoma, suggesting a potential neuroprotective therapy.

Gong Dan, Jun Lin, Tsai James C

This study found Medicare payment changes did not significantly alter most glaucoma procedure volumes, but lower payments for laser iridotomy and scleral reinforcement were linked to increased service volume.

Kaplowitz Kevin, Yung Edward, Flynn Rachel, Tsai James C

Vitreous block, a rare glaucoma, is now better managed with modern imaging and surgical techniques, improving patient outcomes.

Konstas Anastasios G P, Quaranta Luciano, Katsanos Andreas, Riva Ivano, Tsai James C, Giannopoulos Theodoros et al.

This study compared preservative-free tafluprost and latanoprost for 24-hour IOP control in glaucoma/OHT. Both achieved similar overall IOP reduction, but tafluprost showed less fluctuation, offering nuanced treatment choices.

Christakis Panos G, Tsai James C, Kalenak Jeffrey W, Zurakowski David, Cantor Louis B, Kammer Jeffrey A et al.

Comparing Ahmed vs. Baerveldt glaucoma implants, Baerveldt showed lower failure and fewer medications at 3 years, but more hypotony-related complications, guiding device selection for refractory glaucoma.

Vohra Rupali, Tsai James C, Kolko Miriam

This review explored inflammation's role in glaucoma, suggesting low-grade inflammation is a potential causal factor for progressive retinal ganglion cell death, offering new therapeutic avenues beyond IOP.

Mattox Cynthia, Tsai James C

The AGS states glaucoma surgery, including laser and incisional procedures, requires the rigorous training of licensed MDs or DOs to ensure highest quality patient care.

Maris Peter J G, Tsai James C, Khatib Nora, Bansal Rajendra, Al-Aswad Lama A

This study compared Ahmed Glaucoma Valve outcomes when implanted posteriorly (with vitrectomy) versus anteriorly. Both methods achieved similar IOP control and success, but posterior placement reduced early flat anterior chambers.

Ni Nina, Tsai James C, Shields M Bruce, Loewen Nils A

Automated visual field testing can transiently elevate IOP in glaucoma patients, potentially affecting subsequent pressure measurements. This effect was less pronounced after surgical control.

Chabi Almira, Varma Rohit, Tsai James C, Lupinacci Robert, Pigeon Joseph, Baranak Christine et al.

This study found preservative-free tafluprost is non-inferior to preservative-free timolol for lowering intraocular pressure in glaucoma, offering an effective and well-tolerated treatment option.

Christakis Panos G, Kalenak Jeffrey W, Zurakowski David, Tsai James C, Kammer Jeffrey A, Harasymowycz Paul J et al.

The AVB study found Baerveldt implants had higher 1-year success rates than Ahmed implants for refractory glaucoma, but required more interventions. This informs surgical device selection.

Christakis Panos G, Tsai James C, Zurakowski David, Kalenak Jeffrey W, Cantor Louis B, Ahmed Iqbal I K

This study compared Ahmed and Baerveldt glaucoma implants, finding similar patient characteristics and intraoperative complications. This baseline data is crucial for future comparisons of their long-term efficacy and safety.

George Mathew K, Tsai James C, Loewen Nils A

Cosmetic iris implants caused bilateral neovascular glaucoma and irreversible severe vision loss in a young woman. This highlights the extreme danger and permanent harm from these procedures.

Tsai James C

This review identified diverse patient, provider, regimen, and environmental factors contributing to poor glaucoma medication adherence, emphasizing the need for tailored, patient-centered interventions to prevent vision loss.

Seth Rajeev K, Abedi Gelareh, Daccache Armand J, Tsai James C

A Taser gun injury caused blunt trauma (glaucoma, iritis, retinal dialysis) and a unique electrical cataract. Clinicians should recognize these ocular sequelae from Taser use.